Filing Details
- Accession Number:
- 0001179110-18-010754
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-22 10:29:59
- Reporting Period:
- 2018-08-20
- Accepted Time:
- 2018-08-22 10:29:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522046 | Beth Taylor | 3000 Kent Ave, Ste A1-100 West Lafayette IN 47906 | Vp Finance & Chief Acctg Offcr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-08-20 | 285 | $18.20 | 71,255 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the sale of 285 shares in a single transaction, at a price per share of $18.2001. The 285 shares were sold to cover taxes, commissions and fees associated with the August 18, 2018 settlement of 938 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold by Merrill Lynch pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934 adopted by the reporting person on July 30, 2018.
Billionaire Hedge Funds
